professorredbag

Author Archives

Stock Options

Since recently becoming a relatively active trader, I’ve had a plethora of promotional emails extolling the powerful profit potential of option plays. Today I did a little research on the subject and came across an article at http://25yearsofprogramming.com/blog/20070411.htm. In one of no less than 13 seemingly sound reasons the author presents NOT to trade in […]

Recent Author Comments

On "The Mysterious Secret of Canada’s East Island Volcano"
Keep the big picture in mind on this one: Climate change http://tinyurl.com/ceyf3ol[...]
On Microblog: In A Brutal Biotech Market, A Reason to Be Excited: Introducing Regado Biosciences
Thought the following would be of interest to the Biotech Bunch here - an excerpt from the article mentioned in the above post. Having been unfairly criticized for not posting any "single bit of rational, solid, incontrovertible, non-PR, non-spin-laden ite[...]
On Microblog: In A Brutal Biotech Market, A Reason to Be Excited: Introducing Regado Biosciences
Another bit to add to the continuing saga of $PVCT http://bit.ly/1fxoXhv I wonder what ranking the Life Sciences Report has. "A unique, free site featuring summaries of articles from major publications, specific recommendations from top worldwide analysts [...]
On Microblog: In A Brutal Biotech Market, A Reason to Be Excited: Introducing Regado Biosciences
It seems and is reasonable to expect in this context, that as in the case of Benitec now and perhaps Provectus a few years ago (I truly don't know details about it's distant past as I have been following them only since June of last year) fledgling biotech[...]
On Microblog: In A Brutal Biotech Market, A Reason to Be Excited: Introducing Regado Biosciences
RE: Dr's response in post 82 above: PVCT is probably best known to the casual observer/researcher and certainly to the FDA and Scientific community that has investigated, as having a "pristine safety profile" and the ONLY treatment that has so far complete[...]
On Microblog: In A Brutal Biotech Market, A Reason to Be Excited: Introducing Regado Biosciences
The Journal of Surgical Oncology is not to be taken lightly. All will be revealed in due course. Amazing indeed. Nay-sayers/disbelievers best keep a crow or two handy. Sarcasm aside, I think it irresponsible to dismiss out of hand the work of any of these [...]
On Microblog: In A Brutal Biotech Market, A Reason to Be Excited: Introducing Regado Biosciences
Platelets are measured for a person’s ability to blood clot. Mine have always been very low, less than 90. However, through 6 major surgeries I have never had a problem with my wounds healing or with internal bleeding, i.e. my clotting is normal. Dr.’[...]
On "This Tiny, Unknown Biotech is About to Unleash Its ‘Holy Grail’ Drug"
Definitely. There is so much going on behind the scenes. First catalyst will be the BTD filing, next the FDA decision, six weeks from that, though a buy-out is strongly possible anywhere along the way. The people at this company are motivated to get the dr[...]
On "This Tiny, Unknown Biotech is About to Unleash Its ‘Holy Grail’ Drug"
We have Michael Jorrin, "Doc Gumshoe", as Travis' and the site's medical go to fellow. He is the logical, and would be an impartial, moderator for a separate discussion thread. There are subscribers here who are interested in specific areas of investment, [...]
On "This Tiny, Unknown Biotech is About to Unleash Its ‘Holy Grail’ Drug"
1610s, "discussion, debate," from Latin dissertationem (nominative dissertatio) "discourse," noun of action from past participle stem of dissertare "debate, argue, examine, harangue," frequentative of disserere "discuss, examine," from dis- "apart" (see di[...]
On "This Tiny, Unknown Biotech is About to Unleash Its ‘Holy Grail’ Drug"
There is a very compassionate aspect to the motivation many of our brave scientists have in pursuing their work that is worth knowing and remembering. The following is from an article in the NY Times: http://tinyurl.com/kvcomuy Peter Culpepper was purs[...]
On "This Tiny, Unknown Biotech is About to Unleash Its ‘Holy Grail’ Drug"
Dr. Dees $PVCT CEO: "What people don't know is that we have been running numerous tests for the Food and Drug Administration... reproductive tox, modern Ames tests, comet micronuclear assay and the drug continues to perform in these tests like in the tri[...]
On "This Tiny, Unknown Biotech is About to Unleash Its ‘Holy Grail’ Drug"
One of the most widely recognized and acclaimed aspects of all the work done to date with PV-10 is it's superior safety profile. The FDA would not have approved a Breakthrough Drug Therapy application for PV-10 if Compassionate Care program recipients and [...]
On "This Tiny, Unknown Biotech is About to Unleash Its ‘Holy Grail’ Drug"
Yes. Discussion, debate, interspersed with humor (wry perhaps but not malicious) is a productive venture. One of my favorite quotes from Shakespeare: "The devil can cite Scripture for his purpose." One must always keep one's mind unlocked with critical key[...]
On "This Tiny, Unknown Biotech is About to Unleash Its ‘Holy Grail’ Drug"
Thank you. You are kind.[...]
On "This Tiny, Unknown Biotech is About to Unleash Its ‘Holy Grail’ Drug"
I'm amazed that $PVCT has generated the kind and number of comments it has, here and elsewhere. I am not a scientist or Doctor of medicine but have studied the philosophy of science and Thomas Kühne in particular for his revolutionary and profound take on[...]
On "This Tiny, Unknown Biotech is About to Unleash Its ‘Holy Grail’ Drug"
If you were warned away from $PVCT because of one man's self-admittedly cursory review of the company and its lead candidate PV-10, then, unfortunately, you have missed a great opportunity. I will not and perhaps for many here need not recap the drama that[...]
On "This Tiny, Unknown Biotech is About to Unleash Its ‘Holy Grail’ Drug"
Take a look at Avita Medical (AVMXY) for related biomed. Their site has quite compelling information. www.avitamedical.com - RECELL Half the price of RXII.[...]
On "This Tiny, Unknown Biotech is About to Unleash Its ‘Holy Grail’ Drug"
Thank you Karma. I'm trying to resolve the issue. Probably will have to change brokers...pain in the gluteus maximus![...]
On "This Tiny, Unknown Biotech is About to Unleash Its ‘Holy Grail’ Drug"
Hello karma, I have done a bit of DD on Benitec and it does look like it could be a good investment. Thanks for the tipoff. However, when I called my broker, MBT Trading, they said they could not purchase the stock, that the marketmakers have control... Su[...]

This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

Connect with Travis

website designed by Gravity Switch